Dulac Edward J Iii Insider Trades

Insider Trading History

Track insider trading activity for Dulac Edward J Iii. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $1.29M 87,543 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.21M 87,543 shares
$13.78
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $2.37M 160,963 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$844k 61,280 shares
$13.78
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $1.47M 99,683 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.8k 6,379 shares
$9.21
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $1.56M 106,062 shares
Last Trade
Jul 23, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$105k 7,462 shares
$14.02
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $1.67M 113,524 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$680k 67,429 shares
$10.09
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Financial Officer
Holding Value $1.42M 96,219 shares
Last Trade
Jul 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.44M 96,219 shares
$25.33
$14.75
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $224k 101,479 shares
Last Trade
Mar 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$19k 2,447 shares
$7.77
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $939k 425,000 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.87M 425,000 shares
$6.76
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $230k 103,926 shares
Last Trade
Jan 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.6k 1,849 shares
$5.72
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $234k 105,775 shares
Last Trade
Jan 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.7k 7,028 shares
$4.37
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $249k 112,803 shares
Last Trade
Jan 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$19k 5,182 shares
$3.66
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $261k 117,985 shares
Last Trade
Dec 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.99k 1,585 shares
$3.15
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $264k 119,570 shares
Last Trade
Aug 18, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.2k 4,718 shares
$2.80
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $275k 124,288 shares
Last Trade
Jul 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$25k 5,182 shares
$4.83
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $939k 425,000 shares
Last Trade
Feb 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 425,000 shares
$6.77
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $286k 129,470 shares
Last Trade
Jan 10, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.4k 7,331 shares
$5.24
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $302k 136,801 shares
Last Trade
Aug 18, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.1k 432 shares
$30.41
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $303k 137,233 shares
Last Trade
Aug 18, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$140k 4,703 shares
$29.75
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $117k 53,058 shares
Last Trade
Jan 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 53,058 shares
$39.87
$2.21
Fate Therapeutics
Fate Therapeutics FATE
Chief Financial Officer
Holding Value $314k 141,936 shares
Last Trade
Jan 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.33M 33,302 shares
$39.87
$2.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up